SOFIA (Bulgaria), January 20 (SeeNews) – Investment funds advised by Citi Venture Capital International (CVCI), have completed the acquisition of 38% of Bulgarian drug maker Huvepharma for 75 million euro ($101 million), local media reported on Thursday.